BRC News

A research team has shown for the first time at UCLH that clinical trials can be embedded into everyday care using the hospital’s electronic health records system.

Eight UCL researchers are recognised for their ground-breaking research and delivery of new benefits to patients.

UCL researchers last week ran a highly successful course supported by the BRC aiming to develop the next generation of researchers in biomarkers in neurodegeneration.

A new research project aims to improve understanding of the unique impact of health conditions on UK Black communities.

The free online service matches volunteers to health and care studies, based on your interests, taking place online or at locations near you.

In the 2024 to 2025 reporting year, UCLH recruited the first participant in the UK in 10 commercial trials, the first participant in Europe on four occasions, and the first globally in two commercial trials.

The world-first pilot project run by researchers at UCL and King’s College London is supported by the BRC.

Newly reported updated results of a study from UCLH and UCL highlights the powerful benefits of a targeted immune therapy for a type of slow-growing blood cancer.

The service is enabling patients to access targeted treatments they desperately need.

The personalised therapy is for adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia.

A team of researchers at UCL and UCLH have identified the key brain regions that are essential for logical thinking and problem solving.

The BRC-supported research project will monitor infections such as Covid-19, flu and norovirus.

The collaboration between UCLH and Roche Pharmaceuticals aimed to identify barriers for which practical and actionable solutions could be found.